Genetic testing is increasingly becoming a common consideration in the clinical approach of dyslipidemia patients. Advances in research in last decade and increased recognition of genetics in biological pathways modulating blood lipid levels created a gap between theoretical knowledge and its applicability in clinical practice. Therefore, it is very important to define the clinical justification of genetic testing in dyslipidemia patients.

中文翻译：

---

基因检测对血脂紊乱的临床影响。

基因检测日益成为血脂异常患者临床治疗中的常见考虑因素。过去十年的研究进展以及对调节血脂水平的生物途径中遗传学的认识不断提高，在理论知识与其临床实践应用之间造成了差距。因此，明确血脂异常患者基因检测的临床合理性非常重要。